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TITLE  
A comprehensive geriatric assessment screening questionnaire (CGA-GOLD) for 
older people undergoing treatment for cancer 
Whittle AK, Kalsi T, Babic-Illman G, Wang Y, Fields P, Ross P, Maisey N, Hughes S, 
Kwan W, Harari D 
 
ABSTRACT 
 
Oncology services do not routinely assess broader needs of older people with 
cancer. This study evaluates a comprehensive geriatric assessment and comorbidity 
screening questionnaire (CGA-GOLD) covering evidence-based domains and quality 
of life (EORTC-QLQ-C30). Patients aged 65+ attending oncology services were 
recruited into [1]Observational cohort (completed CGA-GOLD, received standard 
oncology care) [2]Intervention cohort (responses categorised 'low-risk', ‘high-risk’, 
'possible need' by geriatricians). N=417 observational patients (1002 invited by post, 
418 consented, age 73.9+/-5.4) completed CGA-GOLD in 11.7+/-7.9 minutes, 86.3% 
required no assistance, 3.1% overall missing responses. Multiple problems reported: 
hypertension(18.1%), diabetes(16.9%), dyspnoea on flat surfaces(27.6%), 
polypharmacy(46%), difficulty walking(14.9%), fatigue(40.5%), living alone(30.9%), 
social isolation(11.2%), recent functional dependence(27.8%), urinary 
incontinence(21.4%), falls(13.3%). 237/239 intervention patients completed CGA-
GOLD and consecutive subsets examined. The doctor and nurse specialist 
independently identified same need level in 87.3% (high inter-rater reliability 
kappa=0.80), taking 1-2 min per questionnaire. Need level remained unchanged 
following hospital notes review against responses in 90%(75/83). ‘Possible need’ 
patients were telephoned with change in 29%(16/55) to low-risk and none to high-
risk, confirming high need was not being missed. CGA-GOLD screening 
questionnaire was acceptable to older patients, feasibly administered in NHS cancer 
services, described comorbidities, CGA and QOL needs, and reliably identified 
higher risk patients requiring further input for optimal cancer treatment. 
 
KEY WORDS comprehensive geriatric assessment (CGA), cancer, older, self-report 
questionnaire, screening, comorbidities, quality of life 
 
KEY MESSAGES 
Improving cancer care for older people is a healthcare priority 
 2 
Comprehensive Geriatric Assessment (CGA) screening can identify comorbidities, 
and functional and psychoscocial problems in older people undergoing cancer 
treatment 
CGA-GOLD patient questionnaire was acceptable to older patients 
Patients reported treatable comorbidites, functional and psychosocial difficulties and 
impact on quality of life 
CGA-GOLD reliably identified low and high level of need, highlighting patients who 
would benefit from further optimisation and support 
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INTRODUCTION 
Thirty-six percent of cancers in the UK are diagnosed in people aged 75+, and two-
thirds are aged 65+ [Cancer Research UK 2009-2011]. Older patients (defined as 
65+) may have comorbidities, functional impairments, and psychosocial factors which 
can affect decision making for cancer treatment (surgery, chemotherapy and 
radiotherapy), usually toward more conservative treatment [Department of Health 
(2013), Wildiers et al (2014),Owen et al (2014)]. Crucially, such wider needs can be 
optimised and supported if identified early, improving cancer treatment tolerance and 
survival [Kalsi et al (2015), McCorkle et al (2000), Hurria et al (2012), Caillet et al 
(2011)]. 
 
Currently UK National Health Service (NHS) cancer services have little routine 
assessment beyond performance status assessment and clinical judgement of 
oncologists [Lund et al (1990), Department of Health (2012)]. The widely used 
European Cooperative Oncology Group Performance Status (ECOG-PS) has been 
validated in younger populations to prognosticate survival and chemotherapy toxicity 
[Lund et al (1990), Gosney (2005)], but there is less evidence in older patients 
[Gosney (2005)]. ECOG-PS is a spot observation of physical function - level 2 
(‘requires some assistance’) in an older patient may in fact relate to a number of 
treatable conditions. Use of brief tools without additional assessment in older people 
may lead to over-estimation of comorbidity or frailty, and hence under-treatment of 
cancer [Repetto et al (2002, Extermann et al (1998)].  
 
Comprehensive geriatric assessment (CGA) is a process that assesses and 
optimises comorbidities, and psychological and functional capabilities of an older 
person. CGA is a 4 stage process: [1] screening [2] further assessment for those 
identified as having risk and needs [3] needs-based management (may involve other 
disciplines e.g. physiotherapy) and [4] follow-through to achieve patient-centred goals 
[Stuck et al (1993)]. Inpatient [Ellis et al (2011), Counsell et al (2005)] and outpatient 
[Reuben et al (1999)] geriatrician-delivered CGA has been shown to reduce mortality, 
functional dependency, and length of hospital stay, as have co-management models 
where geriatricians work with orthopaedic [Vidan et al (2005)] and surgical 
colleagues [Harari et al (2007)].   
 
The US National Comprehensive Cancer Network, International Society of Geriatric 
Oncology (SIOG) and European Organisation for Research and Treatment of Cancer 
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(EORTC) all recommend that some form of CGA screening is performed for all older 
cancer patients [Hurria et al (2012), Extermann et al (2005), Pallis et al (2010)]. While 
several oncological publications have investigated CGA, very few have evaluated the 
process beyond initial screening [Wildiers et al (2014), Clough-Gorr et al (2010)]. 
Recent studies have demonstrated that geriatrician delivery of the full process (i.e. 
including optimisation) can influence oncology treatment decision-making [Caillet et 
al (2011), Aliamus et al (2011)] and improve patient outcomes with better 
chemotherapy tolerance [Kalsi et al (2015)]. Screening followed by in-depth 
assessment and management only for those at risk is now the paradigm of choice in 
the UK 5-year Cancer Strategy (2015) and oncological literature [Hurria et al 
(2012),Gosney (2005),Extermann et al (2005), Decoster et al (2015)]. Abbreviated 
screening tools have received scrutiny as they are quick to complete (approximately 
5 minutes) but using such brief tools risks missing clinically important information. G-
8 is the most studied, [Decoster et al (2015), Bellera (2012)] but lacks comorbidity 
assessment, an essential component as recommended by NCIN, [NCIN (2015)] and 
EORTC [Pallis et al (2011)]. The EORTC Elderly Task Force recommended minimum 
dataset for clinical trials includes G-8 but to be substantiated with comorbidities, 
function, and social data [Pallis et al (2011)]  
 
Currently lacking in the CGA-oncology literature is a patient-reported screening tool 
that include more variables than abbreviated tools like G-8 but is sufficiently brief to 
be feasibly administered, and robust enough to identify needs and risk in order to 
trigger an effective management plan. Patient questionnaires have the benefit of 
highlighting patient concerns that will immediately inform the interaction and 
consultation between patient and provider in clinic. CGA patient questionnaires have 
been evaluated in oncology clinics [Clough-Gorr et al (2010), Hurria et al (2007), 
Ingram et al (2002)] and clinical trial settings [Hurria et al (2011)] in Europe and 
America, but these are lengthy assessments. Furthermore this approach has not as 
yet been tested in the UK. The CGA-GOLD (‘Comprehensive Geriatric Assessment-
Geriatric-Oncology Liaison Development’) patient questionnaire was therefore 
developed to provide a practical screening tool for use in busy cancer services and 
this study  evaluates aspects of feasibility and validity.  
 
METHODS 
CGA-GOLD questionnaire development 
The aim was to select an assessment tool that was short and easy enough to use, 
but sufficiently comprehensive to provide enough information about the patient to 
guide clinical decisions on need for further assessment or intervention. Equally as 
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important is the ability of a tool to identify those patients who require no further 
intervention at the point of starting treatment. The CGA literature in older patients 
with and without cancer was reviewed to identify all tested domains as follows: 
physical function, comorbidities, medications, activities of daily living, mood, social 
situation, falls, nutrition, frailty, bladder and bowel problems.[Gosney (2005), 
Extermann et al (2005), Hurria et al (2011)]. A composite of evidence-based 
questions representing all of those domains from validated tools in the geriatric 
[Stuck et al (1993), Counsell et al (2005), Reuben et al (1999)], Harari et al (2008)] 
and oncology literature [Hurria et al (2012), Gosney (2005), Repetto et al (2002), 
Extermann et al (1998), Extermann et al (2005), Ingram et al (2002), Hurria et al 
(2005)] were then included in the 2-page CGA-GOLD questionnaire. Quality of life is 
valued by older patients as a cancer treatment goal [Pinquart (2002)] and although 
recommended as part of holistic assessment in the UK, [NCSI (2015)] is not 
systematically applied. The EORTC-QLQ-C30 was therefore incorporated into CGA-
GOLD; it is cancer-specific, multidimensional and has been validated in older people 
including as a component of CGA screening [Pallis et al (2011), Wedding et al 
(2012), Aaronson (1993)].  A Plan Do Study Act consultation was conducted with 10 
consecutive patients aged 65+ in the Chemotherapy Day Unit applying NHS Institute 
methodology [http://www.institute.nhs.uk (2016)] and consisting of construct validity 
type questioning (how important/useful is this question) and unstructured feedback 
on what additional questions should be included. In addition the users on the steering 
group (older patients who were undergoing or had undergone chemo or 
radiotherapy) were consulted.  As a result 2 questions were added (‘is there anyone 
they can talk to about their cancer’, and ‘are they a caregiver for a dependent’). 
The project steering group, comprising oncologists, geriatricians, nurses, therapists, 
dieticians, palliative care, social care, patient representatives and voluntary 
organisations (Macmillan Cancer Support and Age UK) also contributed to the tested 
version.  
 
An initial pilot was then conducted in 98 consented patients aged 65+ attending 
lymphoma clinic to identify any issues patients may have with completion. This 
showed a good rate of return (93%) with mean completion time of 11.5+7.4 minutes. 
Most patients preferred to complete the questionnaire at home: 47% completed it at 
home and brought it to clinic, 7% completed it in clinic, and 42% returned it by post 
following their clinic visit. These preferences informed application of CGA-GOLD in 
the main study.  
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Design 
Subjects were older people presenting to cancer services within South-East London 
Cancer Network. The setting was the London teaching hospital where they were 
assessed. Patients were referred locally (urban with relatively low socioeconomics) 
and regionally (South England). They were posted project information with time to 
consider participation prior to written consent with no reminders.  The study was 
approved by the national and institutional research ethics committees conforming to 
the provisions of the Declaration of Helsinki. The CGA-GOLD questionnaire is 
attached as an appendix – it is not copyrighted and freely available for use. 
 
First phase testing was conducted in a prospective observational cohort of patients 
aged 65+ (Ethics 09H71865). Patients completed the CGA-GOLD questionnaire and 
received usual care from oncology +/- any other clinical services. As this was an 
observation of usual care, CGA-GOLD data was not made available to oncologists. 
Questionnaires were posted and returned in a self-addressed envelope. Feasibility 
was evaluated by return rate, completion time, whether assistance was required, 
number of missed responses, and prevalence of problems identified by CGA 
screening.  
 
Second phase testing was conducted in the subsequently funded interventional 
cohort study evaluating the impact of geriatrician-delivered CGA in patients aged 70+ 
undergoing cancer treatment (Ethics 11/LO/0695) [Kalsi et al (2015)]. This 
publication provides more information about the design of the observation and 
intervention cohort. CGA-GOLD responses were reviewed by the geriatric team as 
part of the intervention. CGA need was categorised as low-risk (no self-reported 
comorbidities, CGA problems or recent hospital admissions, and ‘no/little difficulty’ in 
function and QOL) or high-risk (>=1 comorbidity and/or CGA problems and/or ‘quite a 
bit/very much’ QOL or functional difficulties). Patients with 1-2 problems were 
‘possible need’ and telephoned to clarify if these were already managed, could be 
managed remotely (e.g. dietician referral for weight loss), or required further in-depth 
assessment and treatment. A related publication reporting this interventional study 
showed that CGA-GOLD categorised 54% as high-risk, 29% low-risk, and 17% 
possible need [Kalsi et al (2015)].  
 
Low-risk patients received no further input but the geriatricians informed the 
oncologists of their fitness. High-risk patients were invited for geriatrician-delivered 
CGA. To validate this method of using CGA-GOLD as a screening tool, a 
consecutive subset of questionnaires were independently reviewed and risk 
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categorised by a senior specialist registrar (SpR) trained in geriatric-oncology and a 
Clinical Nurse Specialist (CNS) trained in geriatrics, and inter-rater agreement 
measured. The clinicians reviewed hospital clinical records, and in a further subset 
evaluated whether this changed their risk category from reviewing the questionnaire 
alone. Validity was based on whether a change in decision-making occurred once 
supplementary information from the notes was examined. The outcome of telephone 
calls for those with ‘possible need’ was documented to further evaluate that risk 
category.  
 
Data analysis 
Demographics were collected using hospital electronic patient records. Data on CGA 
problems, time taken to complete the questionnaire and whether assistance was 
required were CGA-GOLD responses. Clinician risk assessments were data-based 
prospectively at the time of decision-making. Inter-rater reliability was evaluated with 
kappa. SPSS v.19 statistical package was used for data analysis. 
 
RESULTS 
418/1002 (42%) of people sent the project information signed the consent for the 
observational study (February 2010 – October 2012), and 417 completed CGA-
GOLD first round with no prompting. Mean age was 73.9 years +/-5.4 (range 65-92), 
56.9% were men. The commonest cancers were: urological 24.4%(102), lung 
17.9%(75), colorectal 17.5%(73), breast 14.6%(61), gynaecological 9.3%(39). 
Metastatic malignancy was diagnosed in 41.6% at recruitment.  Table 1 lists the 
prevalence of problems elicited from CGA-GOLD; all the CGA and comorbidity 
questions are listed, and some from EORTC-C30. Missing data equates to non-
responses. 
 
Mean completion time was 11.7+/-7.9minutes, and 86.3% (345) reported they 
completed CGA-GOLD without assistance. The overall rate of missing responses 
was low at 3.1%. The questions most often left blank were driving (there was no ‘not 
applicable’ option), and listing medications. .Patients reported marked rates of cardio-
respiratory problems, diabetes, polypharmacy, recent decline in independent 
functioning, mobility difficulties, QOL impact, weight loss, incontinence, falls, and 
depression. Certain questions flagged up a medical problem that should immediately 
prompt further clinical assessment e.g. falls, pain limiting daily activities, dyspnoea on 
flat surfaces, current angina, poorly controlled hypertension or diabetes, bladder or 
bowel incontinence, depression, memory problems and delirium history. 
Combinations of factors provided more in-depth information (e.g. nutritional risk plus 
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difficulty walking outside plus living alone, diarrhoea plus functional dependency, 
depression plus lack of social support), that would indicate a current need for further 
multidisciplinary support (e.g. occupational/physiotherapist, dietician, psychological 
support) . 
 
Thirty-eight percent (239/638) of people sent the project information returned the 
consent for the intervenional cohort (August 2011-February 2013) and 237/239 
completed the questionnaire (age 76.6 +/- 4.9, 70.7% male). The CNS and SPR 
independently reviewed the same questionnaires for 71 patients. The same decision 
was made in 87.3%(62/71) of patients with high inter-rater reliability (kappa=0.80).  
The SpR and CNS independently reviewed questionnaires against the clinical notes 
and the results are presented in Table 2. Decision-making remained unchanged in 
89% (73/82) for SPR, and 90% (75/83) for CNS. Fifty-five patients were called to 
clarify possible need. 29% (16/55) were changed to low risk, and none to high risk, 
confirming that high need was not being missed. Change to low risk was generally 
because identified needs were being managed appropriately by others (e.g. already 
seeing dietician for weight loss, stroke disease already on appropriate management), 
or because symptoms had resolved.  
 
Discussion  
This study demonstrates that the CGA-GOLD questionnaire is a feasible and useful 
CGA screening method for older people presenting to UK cancer services with the 
following findings: 
 Self-completed patient focussed tool including comorbidites, CGA problems 
and QOL 
 Acceptable to older patients (99% return) who largely (86%) completed it 
without assistance 
 Brief (12 minutes) 
 Low number of missing responses (3%) 
 Feasibly completed at home by post or in clinic  
 Identifies low risk patients who do not need further medical review 
 Identifies specific problems that can be addressed by prompt clinical 
assessment in cancer clinic (e.g. BP control, polypharmacy, cardiac review) 
 Clarifies need for further in-depth CGA and/or multidisciplinary involvement 
 Describes CGA problems early on that may affect how people cope with 
cancer treatment, but can be addressed through local resources 
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Review of questionnaire responses by geriatrician nurse and registrar and phone 
calls demonstrated reliable risk categorisation even without notes review. Patients 
deemed to be high risk were not being missed. Provider time to review and risk 
categorise the questionnaire was generally 1-2 minutes. Low risk patients were 
quickly classified as not needing intervention, similarly high risk patients with multiple 
comorbidities and functional difficulties were rapidly categorised for the optimisation 
pathway (which in this project was geriatrician-delivered). The intermediate group 
with a few problems (e.g. 1-2 comorbidities, mild functional difficulties) needed to 
have these discussed to see if they were ongoing. For this project this was done by a 
short phonecall, but within a service setting this discussion and any required 
intervention (e.g. dietician for weight loss, medication review) could practically occur 
in the oncology clinic in context of discussing cancer treatment.  
 
The high inter-rater reliability between the two disciplines additionally supports the 
role of nurse specialists in administering and interpreting CGA-GOLD within cancer 
services. Service models where CGA screening is done by nurses or therapists with 
escalation for those requiring further input have been demonstrated in diverse 
healthcare settings [(Morilla-Herrera et al (2016), McCusker J et al (2003), Harari et 
al ( 2007), Harari et al ( 2007)], and specifically in older cancer patients undergoing 
outpatient chemotherapy [Cancer Services Coming of Age, (2012), Kalsi et al 
(2015)], and being admitted to oncology wards [Klepin et al (2011), Hamaker et al 
(2011)].  The clinical nurse specialist in this study was trained in older persons care 
[Morilla-Herrera et al (2016)] and therefore could implement supportive pathways of 
care for those who screened as higher risk, but the medical optimisation was 
delivered by geriatricians and oncologists.  Benefit of nurse CGA on clinical 
outcomes has been widely demonstrated, but is dependant on the role working within 
a multidisciplinary team.  
 
Geriatric liaison to oncology services have been nationally resourced in a few 
countries (e.g. France, Belgium, Netherlands) but in many others (including the UK) 
this is not established. The method of assessing level of need was therefore largely 
protocolised according to the questionnaire responses for greater generalisability, 
and so if needed can also be applied by clinicians who are not geriatricians such as 
oncology junior doctors and nurse specialists. In this situation the escalation 
pathways would need to well-defined based on availability of local services. Patients 
identified as having more comorbidities and/or CGA needs would ideally be further 
reviewed by a geriatrics service rapidly in order to not delay cancer treatment. 
Geriatric-oncology service delivery models are beginning to emerge in the UK 
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[Cancer Services Coming of Age, Department of Health (2012)] with clinical 
pathways linking screening tools to ongoing care [Kalsi et al (2015)].  
If dedicated geriatric liaison is not available however, a structured risk assessment 
such as CGA-GOLD can form a basis for rapid referral pathways to generic geriatric 
services (e.g. geriatrician CGA clinics, memory clinic, falls service), other medical 
specialities (e.g. cardiac, respiratory, diabetes), primary care, therapies, or social 
support.  
 
This study describes the coexisting needs of older people with cancer of all types. 
The patient-reported functional difficulties in activities of daily living, fatigue, poor 
nutrition and social isolation (11% had no-one to help out even for a few days) are all 
likely to impact how patients cope with treatment, including travelling to hospital 
appointments. Early identification of these issues should trigger arrangements for 
more practical support (e.g. home food delivery, social services for formal care 
packages, subsidised car transport, charitable organisations for befriending). 
Prevalent problems such as urinary incontinence (a common CGA finding as 
previously documented in older cancer patients) [Wedding et al (2007)], falls 
(likewise 24% rate documented in oncology literature [Hurria et al (2005)], and low 
mood can severely impact QOL, but are often overlooked in routine care. These can 
however be effectively managed alongside cancer treatment through relevant 
services (e.g. falls clinic, community continence services, GP/counselling). Several 
patients had chronic diseases that may decompensate as they undergo treatment 
(e.g. diabetes control worsening on steroids, medicated BP dropping with 
dehydration and causing dizziness/falls). If cancer services are aware of these 
comorbidites through CGA screening at the start of surgical and oncological 
treatment, they can proactively put in place measures to reduce toxicity [Kalsi et al 
(2015)]. An important aspect of this proactive care is to advise patients of how to deal 
with potential decompensations during and after treatment, for example (a) arranging 
insulin regimens with diabetic patients so they do not suffer hypoglycaemia with 
reduced oral intake (b) informing hypertensive patients on symptoms of postural 
hypotension and how to reduce their antihypertensive medication dosage should they 
occur (c) providing pelvic floor exercises, dietary/fluid, containment and skin care 
advice to patients at risk of developing urinary and faecal incontinence from chemo 
or radiotherapy. 
 
Most published cancer comorbidity studies are retrospective using data derived from 
cancer registers rather than directly from patients. CGA-GOLD for instance asked 
whether patients were short of breath walking on flat surfaces rather than if they had 
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a diagnosis of lung disease, thus capturing relevant clinical impact. Although not 
formally measured, many comorbidities identified in this study were newly detected. 
A recent US National Cancer Institute Index study found that 10.1% of breast cancer 
patients had ≥1 undetected comorbidity associated with older age and tumour 
factors; following adjustment for these factors undetected comorbidity remained 
significantly associated with lower odds of receiving adjuvant chemotherapy in stage 
1-111 cancer [Griffiths et al (2014)] This reinforces the message that comorbidity 
should be medically optimised first before influencing decisions towards less 
aggressive treatment. Older people are also likely to have chemotherapy 
discontinued or dose-reduced for low-grade toxicities, presenting a further role for 
CGA optimisation during treatment in order to increase the odds of completion of 
curative treatment [Kalsi et al (2014)]  
 
This study is limited by being performed in a single site and the results require 
validation in other settings. The number of assessors of validity and reliability was 
limited to two and though systematic methods were used, other assessors may 
potentially have assessed responses differently. Comorbidities depended on reliable 
self-report; however a recent study compared self-reported comorbidity using a 
patient questionnaire against traditional medical interview in patients with skin cancer 
and showed that the questionnaire identified comorbidity in more patients (88.6% 
versus 79.5%), and when there were discordant observations, was 5 times more 
likely to identify the comorbidity [Lee et al (2015)]. The majority of questionnaire 
responses were validated as reliable having been taken from evidence-based 
sources, but the memory question could be reinforced with another measure such as 
a clock drawing test [Shulman (2000)], though that would have lengthened the 
completion time. The clinical validation of CGA GOLD used the hospital notes as 
corroboration with the limitation that some of the data  provided within the CGA-
GOLD may not be within the notes (though this is also what makes it potentially 
useful). 
 
This study demonstrates the performance of a CGA screening tool in the pressurised 
clinical setting of a national heath service and adds to existing data on screening 
tools. There are now consistent recommendations from scientific consensus groups 
and national bodies to use this type of screening in older people to identify fit patients 
and to optimise those with identified problems. Further research should focus on 
service development around the implementation of screening tools within health care 
systems. The processes and outcomes of integrating CGA-GOLD (and any other 
relevant tools) into oncological clinical practice including how further medical, 
 12 
comorbidity and/or multidisciplinary management is triggered needs further 
evaluation. Outcomes would include whether: 
 oncology decision making is altered by this approach 
 the quality of patient-centred data informing oncology and surgical MDT 
meetings and clinics is enhanced 
 patients are more likely to complete treatment as planned 
 toxicity severity and patient quality of life impact is reduced 
 
Improved cancer care for older people has become a healthcare priority in the UK 
and elsewhere. The 2015 SIOG consensus recommends that a screening tool be 
used in all oncology practices to identify fit older people who should receive full 
treatment, particularly in view  of population studies showing an overall tendency to 
undertreat cancer in older people (Decoster et al, 2015). The UK Department of 
Health’s report ‘Cancer Services Coming of Age’ [Department of Health (2012)] 
highlights the need to improve outcomes for older people with cancer and calls for 
innovative change. It stresses the benefits of engaging elderly care specialists in 
cancer care, and utilising CGA, as an assessment that can impact positively on 
treatment decision making and general quality of care through clinical interventions. 
Not all older people with cancer have complex needs, requiring specialist 
assessment and intervention and so the use of a screening questionnaire would 
assist the allocation of finite resource to the most appropriate patient group, without 
compromising care. The CGA-GOLD questionnaire has demonstrated it is a valid 
and reliable tool that can be feasibly implemented to the UK NHS setting. 
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Table 1 CGA items and prevalence from CGA-GOLD responses in 
observational cohort  
 
CGA item Question Prevalence 
of yes 
responses 
N = 417 
% (n) 
Missing 
data 
% (n) 
Cognition  “Do you have memory problems?”       8.4 (35) 1 (3) 
Delirium history  “Have you ever had episodes of feeling confused?”                            11.6 (48) 1 (5) 
Depression “During the past week, did you feel depressed?”   
Depression: “quite a bit” or “very much”  versus “no 
difficulty” or “a little difficulty”   EORTC QLQ-C30        
10.5 (43) 3 (11) 
Falls  “Have you had 1 or more falls from standing or 
sitting over the past 6 months?”                                               
13.3 (55) 1 (4) 
Visual impairment  “Do you have poor vision that limits what you can 
do?”                              
11.4 (47)  1 (4) 
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Urinary 
incontinence 
 “In the past year have you had urinary leakage that 
has bothered you?” 
21.4 (87)  3 (11) 
Constipation and 
diarrhoea 
" Have you been constipated?" 
 "Have you had diarrhoea?"  
 Bowel difficulties: responding as “quite a bit” or “a 
lot” to either question EORTC QLQ-C30 
16.5 (67)  
7.2 (29)   
3 (12)  
4 (15) 
Nutritional risk  “Have you lost weight or been eating less in the last 
6 months?                      
47.4 (195) 2 (7) 
Dependency with 
Basic activities of 
daily living (BADL) 
6 BADL questions :"Do you have difficulty with..." -  
Bathing 
 stairs 
 toileting 
Transfers 
Dressing 
Walking 
Difficulty defined as reporting "quite a bit" or "very 
much difficulty" 
BADL dependent: "quite a bit" or "very much" in ≥1 
BADL 
 
6.0 (24)  
17.3 (71) 
4.0 (16)  
4.7 (19)  
4.7 (19)  
14.8 (61)  
 
 
23.7 (98)  
 
4 (15) 
2 (8) 
5 (19) 
3 (12) 
3 (12) 
2 (7) 
 
 
1 (4) 
Dependency with 
Instrumental 
activities of Daily 
Living (iADL) 
4 iADL questions: "Do you have difficulty with..."  
Shopping 
 Driving 
Finances 
Public transport 
Difficulty defined as reporting "quite a bit" or "very 
much difficulty" 
iADL dependent: "quite a bit" or "very much" in ≥1 
Iadl 
 
15.7 (62)  
7.0 (24)  
6.7 (27)  
15.4 (61) 
 
 
20.4 (84) 
 
6 (23) 
18 (76) 
4 (15) 
5 (22) 
 
 
2 (7) 
Poor mobility  "Do you have trouble taking a short walk outside 
the house?"  
Poor mobility: “quite a bit” or “very much” versus 
“no difficulty” or “a little difficulty” EORTC QLQ-C30 
13.7 (56)  2 (9) 
Limited exercise 
Tolerance 
“Do you have trouble taking a long walk outside the 
house?"  
Difficulty with exercise: “quite a bit” or “very much” 
versus “no difficulty” or “a little difficulty”  EORTC 
QLQ-C30 
45.5 (187)  2 (7) 
Lives alone  "What is your living situation?"   Lives alone 
Live alone, with partner, with someone else 
30.9 (127) 2 (7) 
QOL impact on 
family life 
 
 “Has your physical condition or medical treatment 
interfered with your family life?” 
Difficulty with family life: “quite a bit” or “very 
much” versus “no difficulty” or “a little difficulty”  
EORTC QLQ-C30 
20.3 (82)  4 (15) 
QOL impact on 
social activities 
 "Has your physical condition or medical treatment 
interfered with your social activities?” 
Difficulty with social activities: “quite a bit” or “very 
much” versus “no difficulty” or “a little difficulty”  
EORTC QLQ-C30 
30.5 (123)  4 (15) 
No practical 
support if needed 
 "Is there a friend, relative or neighbour who would 
take care of you for a few days if necessary?" 
11.2 (46) 2 (7) 
Recent decline in 
independence 
Over the past month have you needed more help 
than usual to take care of yourself? 
27.8 (115) 
 
1 (4) 
Caregiver status Are you a caregiver for someone who depends on 
you? 
8.9 (36) 3 (13) 
No emotional 
social support   
"Is there a friend or relative you feel you can talk to 
about your cancer and cancer treatment?" 
6.1 (25) 1 (6) 
Pain limiting 
activities  
 "Do you have pain which interferes with your daily 
activities?"  
12.5 (51)  3 (11) 
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Limiting pain: “quite a bit” or “very much” versus 
“no difficulty” or “a little difficulty”  EORTC QLQ-C30 
Poor sleep "Have you had trouble sleeping?"  
Sleep difficulty: “quite a bit” or “very much” versus 
“no difficulty” or “a little difficulty”  EORTC QLQ-C30 
24.9 (102) 2 (9) 
Fatigue 3 questions related to fatigue: during the past week 
"did you need to rest?", "have you felt weak?" and 
"were you tired?".  
Fatigue: "quite a bit" or "a lot" to ≥1 question and 
versus "not at all" or "a little" to all 3 questions. 
EORTC-QLQ-C30 
40.5 (167)  1 (6) 
Polypharmacy (>= 
5 regular 
medications) 
“Please list the names of ALL the medications that 
you are taking” 
Do you think you are having any symptoms due to 
your medications? 
46.0 (165) 
 
29.3 (117)  
14 (59) 
 
5 (19) 
Hospital 
admissions 
 "In the previous 12 months, have you been admitted 
to hospital?" 
1-2 times 
 46.8 (185)  
>=3  times 
12.7 (50)  
 
6 (23) 
 
6 (23) 
Diabetes  "Do you have diabetes?" 
. 
16.9 (68) 4 (16) 
Poorly controlled 
hypertension 
"Is your blood pressure generally high when the 
doctor or nurse checks it?" 
18.1 (74)  2 (9) 
Ischaemic heart 
disease 
"Do you suffer from angina or have ever had a heart 
attack?" 
12.1 (50)  1 (6) 
Stroke "Have you ever had a stroke?"    6.8 (28)  1 (4) 
Lung disease "Do you have chronic lung problems?" 17.8 (73)  2 (9) 
Limiting shortness 
of breath 
Do you get short of breath walking on flat surfaces? 27.6 (113)  2 (8) 
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Table 2. Decision-making on need for in-depth CGA based on CGA-GOLD screening 
S
P
R
 D
e
c
is
io
n
 
CNS Decision 
 No CGA need Need CGA Maybe needs 
No CGA need 14 1 2 
Need CGA 1 29 3 
Maybe needs 1 1 19 
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APPENDIX 1. CGA questionnaire 
South-East London Cancer Network / Department of Ageing and Health Guy's and 
St Thomas' NHS Foundation Trust 
 
NAME 
 
DOB 
Date  
 
In the previous 12 months have you been admitted to a hospital? 
Not at all    
1 -2 times    
3 or more times   
Don't know    
 
Do you have diabetes?  
I do not have diabetes        
    
My diabetes control is usually good (blood sugars below 10)   
   
My diabetes is usually fair (blood sugars 10 or above)      
   
Don't know          
  
 
Is your blood pressure generally high when the doctor or nurse checks it?  
No    
Yes    
Don't know   
 
Do you suffer from angina or have you ever had a heart attack? 
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No    
Yes    
Don't know   
 
Have you ever had a stroke? 
No    
Yes    
Don't know   
 
Do you have chronic lung problems?  
No    
Yes    
Don't know   
 
Do you get short of breath walking on flat surfaces?  
No    
Yes    
Don't know   
 
Have you had 1 or more falls from standing or sitting over the past 6 months? 
No    
Yes    
Don't know   
 
Do you have significant memory problems?    
No    
Yes    
Don't know   
 
Have you ever had episodes of feeling confused?    
 23 
No    
Yes    
Don't know   
 
Do you have poor vision that limits what you can do? 
No    
Yes    
Don't know   
 
Over the past month have you needed more help than usual to take care of 
yourself? 
No    
Yes    
Don't know   
 
Do you have difficulty with any of the following? 
      Not   A little   Quite a bit    A lot 
      at all 
Bathing yourself                   
Climbing stairs                   
Getting to the toilet                   
Moving from bed to chair or standing up                
Dressing yourself                   
Walking                    
Driving                         
Taking public transport                    
Shopping for food                     
Managing financial affairs                    
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Is there a friend, relative or neighbour who would take care of you for a few 
days if necessary?  
No    
Yes    
Don't know   
 
Is there a friend or relative you feel you can talk to about your cancer and 
cancer treatment? 
No    
Yes    
Don't know      
 
What is your living situation?    
Live alone      
Live with partner     
Live with someone other than partner  
Live in sheltered housing    
 
Are you a caregiver for someone who depends on you?    
No    
Yes    Who? ________________ 
 
In the past year have you had urinary leakage that has bothered you? 
No    
Yes    
Don't know   
 
Have you lost weight or been eating less in last 6 months? 
No    
Yes    
 25 
Don't know   
 
Please list the names of ALL the medications that you are taking 
 
 
 
 
 
 
 
 
Don't know   
 
Do you think you are having any symptoms due to your medications? 
No    
Yes    
Don't know   
 
Are there any other problems that you would like to tell us about? 
 
THANK YOU 
 
 
 
 
 
 [2] EORTC QLQ C30 (V3) - Validated quality of life questionnaire –  
 
We are interested in some things about you and your health.  Please answer all of 
the questions yourself by circling the number that best applies to you.  There are no 
“right” or “wrong” answers. 
 
 
Not at    A   Quite Very 
        all little a bit       much 
 
1.  Do you have any trouble doing strenuous activities  1 2 3 4 
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     like carrying a heavy shopping bag or a suitcase 
 
2.  Do you have any trouble taking a long walk?  1 2 3 4 
 
3.  Do you have any trouble taking a short walk   
     outside of the house?     1 2 3 4 
 
4.  Do you need to stay in bed or a chair during the  
     day?       1 2 3 4 
 
5.  Do you need help with eating, dressing, washing 
     yourself or using the toilet?    1 2 3 4 
 
During the past week: 
 
6.  Were you limited in doing either your work or 
     other daily activities?     1 2 3 4 
 
7.  Were you limited in pursuing your hobbies or other  
     leisure time activities?     1 2 3 4 
 
8.  Were you short of breath?     1 2 3 4 
 
9.  Have you had pain?     1 2 3 4 
 
10. Did you need to rest?     1 2 3 4 
 
11. Have you had trouble sleeping?    1 2 3 4 
 
12. Have you felt weak?     1 2 3 4 
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13. Have you lacked appetite?    1 2 3 4 
 
14. Have you felt nauseated?    1 2 3 4 
 
15. Have you vomited?     1 2 3 4 
 
16. Have you been constipated?    1 2 3 4 
 
17. Have you had diarrhoea?     1 2 3 4 
 
18. Were you tired?      1 2 3 4 
 
19. Did pain interfere with your daily activities  1 2 3 4
  
 
20. Have you had difficulty in concentrating on things, 
     like reading a newspaper or watching television? 1 2 3 4 
 
21. Did you feel tense?     1 2 3 4 
 
 
During the past week: 
 
22. Did you worry?      1 2 3 4 
 
23. Did you feel irritable?     1 2 3 4 
 
24. Did you feel depressed?     1 2 3 4 
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25. Have you had difficulty remembering things?  1 2 3 4 
 
26. Has your physical condition or medical treatment 
     interfered with your family life?    1 2 3 4 
 
27. Has your physical condition or medical treatment 
     interfered with your social activities?   1 2 3 4 
 
28. Has your physical condition or medical treatment caused 
     you financial difficulties?     1 2 3 4 
 
 
For the following questions please circle the number between 1 and 7 that best  
applies to you 
 
29. How would you rate your overall health during the past week? 
 1 2 3 4 5 6 
Very poor          Excellent 
 
30. How would you rate your overall quality of life during the past week? 
 1 2 3 4 5 6 
Very poor      Excellent 
 
 
 
Did you need someone to assist you in completing this questionnaire? 
No    
Yes    
 
About how long did it take you to complete the questionnaire? 
__________ minutes 
Don't know   
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THANK YOU
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